OncoSec Medical Inc (OQ:ONCS)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for ONCS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 4th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 3/20 May 29/20 DelAversano Robert J Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 54,054  
Jun 3/20 May 29/20 DelAversano Robert J Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -8,679 $2.23
Jun 3/20 May 29/20 DelAversano Robert J Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 25,362  
Jun 3/20 May 29/20 Zhou Chao Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 25,000  
Jun 3/20 May 29/20 Dalesandro Margaret Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 37,500  
Jun 3/20 May 29/20 Zhao Yuhang Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 25,000  
Jun 3/20 May 29/20 Ward Robert Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 25,000  
Jun 3/20 May 29/20 Smith Kevin Raymond Merrill Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 25,000  
Jun 3/20 May 29/20 O'Connor Daniel J. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 304,000  
Jun 3/20 May 29/20 O'Connor Daniel J. Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -44,471 $2.23
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ONCS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 4th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jun 3/20 May 29/20 DelAversano Robert J Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 54,054  
Jun 3/20 May 29/20 DelAversano Robert J Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -8,679 $2.23
Jun 3/20 May 29/20 DelAversano Robert J Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 25,362  
Jun 3/20 May 29/20 Zhou Chao Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 25,000  
Jun 3/20 May 29/20 Dalesandro Margaret Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 37,500  
Jun 3/20 May 29/20 Zhao Yuhang Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 25,000  
Jun 3/20 May 29/20 Ward Robert Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 25,000  
Jun 3/20 May 29/20 Smith Kevin Raymond Merrill Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 25,000  
Jun 3/20 May 29/20 O'Connor Daniel J. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 304,000  
Jun 3/20 May 29/20 O'Connor Daniel J. Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -44,471 $2.23
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ONCS

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Seattle Genetics (OQ:SGEN)
Alnylam Pharmaceuticals (OQ:ALNY)